EXAGEN INC. Selling, General and Administrative Expense
EXAGEN INC. (XGN) reported Selling, General and Administrative Expense of $12.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-04
- EXAGEN INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $12.51M, a 8.41% increase year-over-year.
- EXAGEN INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $12.07M, a 7.69% increase year-over-year.
- EXAGEN INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $12.42M, a 21.76% increase year-over-year.
- EXAGEN INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $11.45M, a 12.61% increase year-over-year.
- EXAGEN INC. selling, general and administrative expense for fiscal 2025 was $46.62M, a 12.67% increase from fiscal 2024.
- EXAGEN INC. selling, general and administrative expense for fiscal 2024 was $41.37M, a 12.77% decline from fiscal 2023.
- EXAGEN INC. selling, general and administrative expense for fiscal 2023 was $47.43M, a 8.82% decline from fiscal 2022.
- EXAGEN INC. selling, general and administrative expense for fiscal 2022 was $52.02M, a 16.79% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.51M 10-Q · filed 2026-08-04 | $24.58M 10-Q · filed 2026-08-04 | $37.00M derived: sum of 3 quarters · filed 2026-08-04 | $48.45M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $12.07M 10-Q · filed 2026-05-11 | $24.49M derived: sum of 2 quarters · filed 2026-05-11 | $35.94M derived: sum of 3 quarters · filed 2026-05-11 | $47.48M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $12.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $23.87M derived: sum of 2 quarters · filed 2026-03-10 | $35.41M derived: sum of 3 quarters · filed 2026-08-04 | $46.62M 10-K · filed 2026-03-10 |
| 2025-09-30 | $11.45M 10-Q · filed 2025-11-04 | $22.99M derived: sum of 2 quarters · filed 2026-08-04 | $34.19M 10-Q · filed 2025-11-04 | $44.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $11.54M 10-Q · filed 2026-08-04 | $22.75M 10-Q · filed 2026-08-04 | $32.95M derived: sum of 3 quarters · filed 2026-08-04 | $43.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $11.20M 10-Q · filed 2026-05-11 | $21.41M derived: sum of 2 quarters · filed 2026-05-11 | $31.57M derived: sum of 3 quarters · filed 2026-05-11 | $42.03M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $20.37M derived: sum of 2 quarters · filed 2026-03-10 | $30.83M derived: sum of 3 quarters · filed 2026-03-10 | $41.37M 10-K · filed 2026-03-10 |
| 2024-09-30 | $10.16M 10-Q · filed 2025-11-04 | $20.63M derived: sum of 2 quarters · filed 2025-11-04 | $31.17M 10-Q · filed 2025-11-04 | $43.38M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $10.46M 10-Q · filed 2025-07-29 | $21.01M 10-Q · filed 2025-07-29 | $33.22M derived: sum of 3 quarters · filed 2025-07-29 | $44.60M derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | $10.54M 10-Q · filed 2025-05-05 | $22.76M derived: sum of 2 quarters · filed 2025-05-05 | $34.13M derived: sum of 3 quarters · filed 2025-05-05 | $46.09M derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $12.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $23.59M derived: sum of 2 quarters · filed 2025-03-11 | $35.54M derived: sum of 3 quarters · filed 2025-03-11 | $47.43M 10-K · filed 2025-03-11 |
| 2023-09-30 | $11.38M 10-Q · filed 2024-11-12 | $23.33M derived: sum of 2 quarters · filed 2024-11-12 | $35.21M 10-Q · filed 2024-11-12 | $48.02M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $11.95M 10-Q · filed 2024-08-05 | $23.84M 10-Q · filed 2024-08-05 | $36.65M derived: sum of 3 quarters · filed 2024-08-05 | $50.80M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $11.88M 10-Q · filed 2024-05-13 | $24.70M derived: sum of 2 quarters · filed 2024-05-13 | $38.85M derived: sum of 3 quarters · filed 2024-05-13 | $51.75M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $12.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $26.96M derived: sum of 2 quarters · filed 2024-03-18 | $39.87M derived: sum of 3 quarters · filed 2024-03-18 | $52.02M 10-K · filed 2024-03-18 |
| 2022-09-30 | $14.15M 10-Q · filed 2023-11-13 | $27.05M derived: sum of 2 quarters · filed 2023-11-13 | $39.21M 10-Q · filed 2023-11-13 | $51.01M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $12.90M 10-Q · filed 2023-08-07 | $25.05M 10-Q · filed 2023-08-07 | $36.86M derived: sum of 3 quarters · filed 2023-08-07 | $48.38M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $12.15M 10-Q · filed 2023-05-15 | $23.95M derived: sum of 2 quarters · filed 2023-05-15 | $35.48M derived: sum of 3 quarters · filed 2023-05-15 | $46.65M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $23.33M derived: sum of 2 quarters · filed 2023-03-20 | $34.50M derived: sum of 3 quarters · filed 2023-03-20 | $44.54M 10-K · filed 2023-03-20 |
| 2021-09-30 | $11.53M 10-Q · filed 2022-11-21 | $22.70M derived: sum of 2 quarters · filed 2022-11-21 | $32.74M 10-Q · filed 2022-11-21 | $42.67M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $11.17M 10-Q/A · filed 2022-11-21 | $21.21M 10-Q/A · filed 2022-11-21 | $31.14M derived: sum of 3 quarters · filed 2022-11-21 | $40.34M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $10.04M 10-Q · filed 2022-05-11 | $19.97M derived: sum of 2 quarters · filed 2022-05-11 | $29.17M derived: sum of 3 quarters · filed 2022-05-11 | $37.45M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $19.13M derived: sum of 2 quarters · filed 2022-03-22 | $27.41M derived: sum of 3 quarters · filed 2022-03-22 | $37.03M 10-K · filed 2022-03-22 |
| 2020-09-30 | $9.20M 10-Q · filed 2021-11-10 | $17.48M derived: sum of 2 quarters · filed 2021-11-10 | $27.10M 10-Q · filed 2021-11-10 | $35.02M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $8.28M 10-Q · filed 2021-08-09 | $17.90M 10-Q · filed 2021-08-09 | $25.82M derived: sum of 3 quarters · filed 2021-08-09 | $33.12M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $9.63M 10-Q · filed 2021-05-11 | $17.54M derived: sum of 2 quarters · filed 2021-05-11 | $24.85M derived: sum of 3 quarters · filed 2021-05-11 | $32.15M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $7.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $15.22M derived: sum of 2 quarters · filed 2021-03-16 | $22.52M derived: sum of 3 quarters · filed 2021-03-16 | $28.70M 10-K · filed 2021-03-16 |
| 2019-09-30 | $7.31M 10-Q · filed 2020-11-10 | $14.61M derived: sum of 2 quarters · filed 2020-11-10 | $20.79M 10-Q · filed 2020-11-10 | $26.04M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $7.30M 10-Q · filed 2020-07-28 | $13.48M 10-Q · filed 2020-07-28 | $18.74M derived: sum of 3 quarters · filed 2020-07-28 | $23.67M derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-03-31 | $6.18M 10-Q · filed 2020-05-11 | $11.44M derived: sum of 2 quarters · filed 2020-05-11 | $16.37M derived: sum of 3 quarters · filed 2020-05-11 | |
| 2018-12-31 | $5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $10.19M derived: sum of 2 quarters · filed 2020-03-25 | $19.68M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $4.93M 10-Q · filed 2019-11-12 | $14.42M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |